Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""International journal of antimicrobial agents [Int J Antimicrob Agents] NLMUID: 9111860"" wg kryterium: JN


Tytuł :
Azithromycin, a questionable treatment for COVID-19.
Autorzy :
Belfaqeeh O; International Medicine Program, George Washington University School of Medicine and Health Sciences, Washington DC, USA. Electronic address: .
Janapala RN; International Medicine Program, George Washington University School of Medicine and Health Sciences, Washington DC, USA.
Patel J; International Medicine Program, George Washington University School of Medicine and Health Sciences, Washington DC, USA.
Alhashmi A; International Medicine Program, George Washington University School of Medicine and Health Sciences, Washington DC, USA.
Pourmand A; International Medicine Program, George Washington University School of Medicine and Health Sciences, Washington DC, USA.
Pokaż więcej
Źródło :
International journal of antimicrobial agents [Int J Antimicrob Agents] 2021 Jan 19, pp. 106280. Date of Electronic Publication: 2021 Jan 19.
Typ publikacji :
Letter
Opinia redakcyjna
Tytuł :
Outcomes associated with recent guideline recommendations removing metronidazole for treatment of non-severe Clostridioides difficile infection: a retrospective, observational, nationwide cohort study.
Autorzy :
Gentry CA; Pharmacy Service, Oklahoma City VA Health Care System, Oklahoma City, USA. Electronic address: .
Campbell DL; Pharmacy Service, Oklahoma City VA Health Care System, Oklahoma City, USA.
Williams RJ; Pharmacy Service, Oklahoma City VA Health Care System, Oklahoma City, USA.
Pokaż więcej
Źródło :
International journal of antimicrobial agents [Int J Antimicrob Agents] 2021 Jan 17, pp. 106282. Date of Electronic Publication: 2021 Jan 17.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Pharmacokinetics of colistin in cerebrospinal fluid after intraventricular administration alone in intracranial infections.
Autorzy :
Ni M; Department of Pharmacy, Shanghai Tenth People's Hospital, Tongji University School of Medicine, 301 Middle Yanchang Road, Shanghai 200072, China.
Zhao L; Department of Pharmacy, Shanghai Baoshan Luodian Hospital, Shanghai, China.
Zhang WJ; Department of Pharmacy, Shanghai Tenth People's Hospital, Tongji University School of Medicine, 301 Middle Yanchang Road, Shanghai 200072, China; Department of Pharmacy, Inner Mongolia Autonomous Region People's Hospital, Inner Mongolia Autonomous Region, China.
Ma JW; Department of Pharmacy, Shanghai Tenth People's Hospital, Tongji University School of Medicine, 301 Middle Yanchang Road, Shanghai 200072, China.
Zhang GY; Department of Pharmacy, Shanghai Tenth People's Hospital, Tongji University School of Medicine, 301 Middle Yanchang Road, Shanghai 200072, China.
Cui DM; Department of Neurosurgery, Shanghai Tenth People's Hospital, Tongji University School of Medicine, 301 Middle Yanchang Road, Shanghai 200072, China.
Wang K; Department of Neurosurgery, Shanghai Tenth People's Hospital, Tongji University School of Medicine, 301 Middle Yanchang Road, Shanghai 200072, China.
Fei YB; Department of Pharmacy, Shanghai Tenth People's Hospital, Tongji University School of Medicine, 301 Middle Yanchang Road, Shanghai 200072, China.
Gao L; Department of Neurosurgery, Shanghai Tenth People's Hospital, Tongji University School of Medicine, 301 Middle Yanchang Road, Shanghai 200072, China. Electronic address: .
Shen FM; Department of Pharmacy, Shanghai Tenth People's Hospital, Tongji University School of Medicine, 301 Middle Yanchang Road, Shanghai 200072, China. Electronic address: .
Pokaż więcej
Źródło :
International journal of antimicrobial agents [Int J Antimicrob Agents] 2021 Jan 16, pp. 106281. Date of Electronic Publication: 2021 Jan 16.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Dysbiosis of the rat vagina is efficiently rescued by vaginal microbiota transplantation or probiotic combination.
Autorzy :
Chen T; National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang 330031, PR China. Electronic address: .
Xia C; National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang 330031, PR China.
Hu H; National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang 330031, PR China.
Wang H; National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang 330031, PR China.
Tan B; Department of Obstetrics & Gynecology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, PR China.
Tian P; National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang 330031, PR China.
Zhao X; National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang 330031, PR China.
Wang L; National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang 330031, PR China.
Han Y; National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang 330031, PR China.
Deng KY; National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang 330031, PR China.
Wei H; Precision Medicine Institute, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510080, PR China. Electronic address: .
Xin HB; National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang 330031, PR China. Electronic address: .
Pokaż więcej
Źródło :
International journal of antimicrobial agents [Int J Antimicrob Agents] 2021 Jan 09, pp. 106277. Date of Electronic Publication: 2021 Jan 09.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Evaluating the emergence of nonsusceptibility among Pseudomonas aeruginosa respiratory isolates from a phase 3 clinical trial for treatment of nosocomial pneumonia (ASPECT-NP).
Autorzy :
Johnson MG; Merck & Co., Inc., Kenilworth, NJ, USA. Electronic address: .
Bruno C; Merck & Co., Inc., Kenilworth, NJ, USA.
Castanheira M; JMI Laboratories, North Liberty, IA, USA.
Yu B; Merck & Co., Inc., Kenilworth, NJ, USA.
Huntington JA; Merck & Co., Inc., Kenilworth, NJ, USA.
Carmelitano P; Merck & Co., Inc., Kenilworth, NJ, USA.
Rhee EG; Merck & Co., Inc., Kenilworth, NJ, USA.
De Anda C; Merck & Co., Inc., Kenilworth, NJ, USA.
Motyl M; Merck & Co., Inc., Kenilworth, NJ, USA.
Pokaż więcej
Źródło :
International journal of antimicrobial agents [Int J Antimicrob Agents] 2021 Jan 09, pp. 106278. Date of Electronic Publication: 2021 Jan 09.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
High carriage of ESBL-producing Enterobacteriaceae associated with sexual activity among men who have sex with men.
Autorzy :
van Bilsen WPH; Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, The Netherlands.
van Dulm E; Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, The Netherlands. Electronic address: .
Matser A; Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, The Netherlands.
Linde I; Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, The Netherlands.
van Duijnhoven YTHP; Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, The Netherlands.
Prins JM; Department of Internal Medicine, Division of Infectious Diseases, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Prins M; Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, The Netherlands; Department of Internal Medicine, Division of Infectious Diseases, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Boyd A; Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, The Netherlands; HIV Monitoring Foundation, Amsterdam, The Netherlands.
van Dam AP; Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, The Netherlands.
Pokaż więcej
Źródło :
International journal of antimicrobial agents [Int J Antimicrob Agents] 2021 Jan 09, pp. 106276. Date of Electronic Publication: 2021 Jan 09.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Passive immunization and its rebirth in the era of the COVID-19 pandemic.
Autorzy :
Pavia CS; Department of Biomedical Sciences, NYIT College of Osteopathic Medicine, New York Institute of Technology, Old Westbury, NY; Division of Infectious Diseases, New York Medical College, Valhalla, NY, USA. Electronic address: .
Wormser GP; Division of Infectious Diseases, New York Medical College, Valhalla, NY, USA.
Pokaż więcej
Źródło :
International journal of antimicrobial agents [Int J Antimicrob Agents] 2021 Jan 02, pp. 106275. Date of Electronic Publication: 2021 Jan 02.
Typ publikacji :
Journal Article; Review
Czasopismo naukowe
Tytuł :
Safety profile of hydroxychloroquine and azithromycin combined treatment in COVID-19 patients.
Autorzy :
Gautret P; IHU-Méditerranée Infection, Marseille, France; Aix Marseille Univ, IRD, AP-HM, SSA, VITROME, Marseille, France.
Honoré S; Service Pharmacie, Hôpital Timone, AP-HM, Marseille, France; Laboratoire de Pharmacie Clinique, Aix Marseille Université, Marseille, France.
Lagier JC; IHU-Méditerranée Infection, Marseille, France; Aix Marseille Univ, IRD, APHM, MEPHI, Marseille, France.
Raoult D; IHU-Méditerranée Infection, Marseille, France; Aix Marseille Univ, IRD, APHM, MEPHI, Marseille, France. Electronic address: .
Pokaż więcej
Źródło :
International journal of antimicrobial agents [Int J Antimicrob Agents] 2021 Jan; Vol. 57 (1), pp. 106236.
Typ publikacji :
Letter
MeSH Terms :
Antiviral Agents/*therapeutic use
Azithromycin/*therapeutic use
COVID-19/*drug therapy
Hydroxychloroquine/*therapeutic use
SARS-CoV-2/*pathogenicity
Anti-Bacterial Agents/therapeutic use ; Antimalarials/therapeutic use ; COVID-19/virology ; Clinical Trials as Topic ; Drug Combinations ; Drug Interactions ; Drug Repositioning ; Drug Synergism ; Electrocardiography ; Humans ; Hyperkalemia/prevention & control ; Hypokalemia/prevention & control ; Long QT Syndrome/prevention & control
Opinia redakcyjna
Tytuł :
Azithromycin potentiates avian IgY effect against Pseudomonas aeruginosa in a murine pulmonary infection model.
Autorzy :
Thomsen K; Department of Clinical Microbiology, Copenhagen University Hospital, Rigshospitalet, Henrik Harpestrengsvej 4A, 2100-DK Copenhagen, Denmark. Electronic address: .
Christophersen L; Department of Clinical Microbiology, Copenhagen University Hospital, Rigshospitalet, Henrik Harpestrengsvej 4A, 2100-DK Copenhagen, Denmark.
Lerche CJ; Department of Clinical Microbiology, Copenhagen University Hospital, Rigshospitalet, Henrik Harpestrengsvej 4A, 2100-DK Copenhagen, Denmark.
Holmgaard DB; Department of Clinical Microbiology, Slagelse Hospital, Slagelse, Denmark.
Calum H; Department of Clinical Microbiology, Hvidovre Hospital, Copenhagen, Denmark.
Høiby N; Department of Clinical Microbiology, Copenhagen University Hospital, Rigshospitalet, Henrik Harpestrengsvej 4A, 2100-DK Copenhagen, Denmark; Institute of Immunology and Microbiology, Costerton Biofilm Center, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Moser C; Department of Clinical Microbiology, Copenhagen University Hospital, Rigshospitalet, Henrik Harpestrengsvej 4A, 2100-DK Copenhagen, Denmark.
Pokaż więcej
Źródło :
International journal of antimicrobial agents [Int J Antimicrob Agents] 2021 Jan; Vol. 57 (1), pp. 106213. Date of Electronic Publication: 2020 Oct 23.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Letter to the editor about "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial".
Autorzy :
Saad MO; Department of Pharmacy, Al-Wakra Hospital, Hamad Medical Corporation, PO Box 82228 Doha, Qatar. Electronic address: .
Pokaż więcej
Źródło :
International journal of antimicrobial agents [Int J Antimicrob Agents] 2021 Jan; Vol. 57 (1), pp. 106171.
Typ publikacji :
Letter
MeSH Terms :
Antiviral Agents/*therapeutic use
Azithromycin/*therapeutic use
COVID-19/*drug therapy
Hydroxychloroquine/*therapeutic use
SARS-CoV-2/*pathogenicity
Anti-Bacterial Agents/therapeutic use ; Antimalarials/therapeutic use ; COVID-19/virology ; Clinical Trials as Topic ; Drug Combinations ; Drug Repositioning ; Humans ; Uncertainty
Opinia redakcyjna
Tytuł :
Response to the use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature.
Autorzy :
Gautret P; IHU-Méditerranée Infection, Marseille, France; Aix Marseille Univ, IRD, AP-HM, SSA, VITROME, Marseille, France.
Hoang VT; IHU-Méditerranée Infection, Marseille, France; Aix Marseille Univ, IRD, AP-HM, SSA, VITROME, Marseille, France; Thai Binh University of Medicine and Pharmacy, Thai Binh, Vietnam.
Honoré S; Service Pharmacie, Hôpital Timone, AP-HM, Marseille, France; Laboratoire de Pharmacie Clinique, Aix Marseille Université, Marseille, France.
Roussel Y; IHU-Méditerranée Infection, Marseille, France; Aix Marseille Univ, IRD, APHM, MEPHI, Marseille, France.
Million M; IHU-Méditerranée Infection, Marseille, France; Aix Marseille Univ, IRD, APHM, MEPHI, Marseille, France.
Lagier JC; IHU-Méditerranée Infection, Marseille, France; Aix Marseille Univ, IRD, APHM, MEPHI, Marseille, France.
Raoult D; IHU-Méditerranée Infection, Marseille, France; Aix Marseille Univ, IRD, APHM, MEPHI, Marseille, France. Electronic address: .
Pokaż więcej
Źródło :
International journal of antimicrobial agents [Int J Antimicrob Agents] 2021 Jan; Vol. 57 (1), pp. 106241.
Typ publikacji :
Letter; Comment
Opinia redakcyjna
Tytuł :
LPD-12: a promising lipopeptide to control COVID-19.
Autorzy :
Chowdhury T; Central Research Facility, Indian Institute of Technology Kharagpur, Kharagpur, India.
Baindara P; Department of Molecular Microbiology and Immunology, University of Missouri, Columbia, USA.
Mandal SM; Central Research Facility, Indian Institute of Technology Kharagpur, Kharagpur, India. Electronic address: .
Pokaż więcej
Źródło :
International journal of antimicrobial agents [Int J Antimicrob Agents] 2021 Jan; Vol. 57 (1), pp. 106218. Date of Electronic Publication: 2020 Nov 06.
Typ publikacji :
Journal Article
MeSH Terms :
Angiotensin-Converting Enzyme 2/*metabolism
Antiviral Agents/*metabolism
Lipopeptides/*chemistry
Spike Glycoprotein, Coronavirus/*metabolism
Angiotensin-Converting Enzyme 2/chemistry ; Antiviral Agents/chemistry ; Antiviral Agents/pharmacology ; Drug Evaluation, Preclinical ; Lipopeptides/pharmacology ; Molecular Docking Simulation ; Peptides, Cyclic/chemistry ; Peptides, Cyclic/metabolism ; Spike Glycoprotein, Coronavirus/chemistry
Czasopismo naukowe
Tytuł :
Using the clinical information system and self-supervision to rationalize the need for antibiotic stewardship: An interventional study in a 2000-bed university hospital.
Autorzy :
Viala B; Infectious and Tropical Diseases Department, CHU Montpellier, Montpellier, France. Electronic address: .
Villiet M; Clinical Pharmacy Department, CHU Montpellier, Montpellier, France.
Redor A; Infectious and Tropical Diseases Department, CHU Montpellier, Montpellier, France.
Didelot MN; Microbiology Department, CHU Montpellier, Montpellier, France.
Makinson A; Infectious and Tropical Diseases Department, CHU Montpellier, Montpellier, France.
Reynes J; Infectious and Tropical Diseases Department, CHU Montpellier, Montpellier, France.
Le Moing V; Infectious and Tropical Diseases Department, CHU Montpellier, Montpellier, France.
Morquin D; Infectious and Tropical Diseases Department, CHU Montpellier, Montpellier, France.
Pokaż więcej
Źródło :
International journal of antimicrobial agents [Int J Antimicrob Agents] 2021 Jan; Vol. 57 (1), pp. 106233. Date of Electronic Publication: 2020 Nov 21.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Safety and efficacy of artemisinin-piperaquine for treatment of COVID-19: an open-label, non-randomised and controlled trial.
Autorzy :
Li G; Institute of Science and Technology Park, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, People's Republic of China.
Yuan M; Department of Intensive Medicine, Hongqi Hospital affiliated to Mudanjiang Medical University, Mudanjiang, Heilongjiang, People's Republic of China.
Li H; Department of Intensive Medicine, Hongqi Hospital affiliated to Mudanjiang Medical University, Mudanjiang, Heilongjiang, People's Republic of China.
Deng C; Artemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China.
Wang Q; Artemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China.
Tang Y; Artemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China.
Zhang H; Institute of Science and Technology Park, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, People's Republic of China.
Yu W; Artemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China.
Xu Q; Institute of Science and Technology Park, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, People's Republic of China.
Zou Y; Artemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China.
Yuan Y; Institute of Science and Technology Park, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, People's Republic of China.
Guo J; Institute of Science and Technology Park, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, People's Republic of China.
Jin C; Department of Intensive Medicine, Hongqi Hospital affiliated to Mudanjiang Medical University, Mudanjiang, Heilongjiang, People's Republic of China.
Guan X; Department of Surgical Intensive Care Unit, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, People's Republic of China. Electronic address: .
Xie F; Department of Intensive Medicine, Hongqi Hospital affiliated to Mudanjiang Medical University, Mudanjiang, Heilongjiang, People's Republic of China. Electronic address: .
Song J; Institute of Science and Technology Park, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, People's Republic of China; Artemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China. Electronic address: .
Pokaż więcej
Źródło :
International journal of antimicrobial agents [Int J Antimicrob Agents] 2021 Jan; Vol. 57 (1), pp. 106216. Date of Electronic Publication: 2020 Nov 02.
Typ publikacji :
Controlled Clinical Trial; Journal Article
MeSH Terms :
Antiviral Agents/*adverse effects
Antiviral Agents/*therapeutic use
Artemisinins/*therapeutic use
COVID-19/*drug therapy
Quinolines/*therapeutic use
Adult ; Artemisinins/adverse effects ; Drug Therapy, Combination ; Female ; Humans ; Long QT Syndrome/chemically induced ; Lung Diseases/diagnostic imaging ; Lung Diseases/drug therapy ; Lung Diseases/virology ; Male ; Middle Aged ; Quinolines/adverse effects ; RNA, Viral/blood ; SARS-CoV-2/genetics ; Viral Load
SCR Protocol :
COVID-19 drug treatment
Czasopismo naukowe
Tytuł :
Referring to the study: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial.
Autorzy :
Dos Santos MR; Instituto do Coração do Hospital das Clínicas da Universidade de São Paulo (InCor HC-FMUSP), Brazil. Electronic address: .
Pokaż więcej
Źródło :
International journal of antimicrobial agents [Int J Antimicrob Agents] 2021 Jan; Vol. 57 (1), pp. 106176.
Typ publikacji :
Letter
MeSH Terms :
Antiviral Agents/*therapeutic use
Azithromycin/*therapeutic use
COVID-19/*drug therapy
Hydroxychloroquine/*therapeutic use
SARS-CoV-2/*pathogenicity
Anti-Bacterial Agents/therapeutic use ; Antimalarials/therapeutic use ; COVID-19/virology ; Clinical Trials as Topic ; Drug Combinations ; Drug Repositioning ; Humans ; Uncertainty
Opinia redakcyjna
Tytuł :
Effect of hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, an update with an intention-to-treat analysis and clinical outcomes.
Autorzy :
Gautret P; IHU-Méditerranée Infection, Marseille, France; Aix Marseille Univ, IRD, AP-HM, SSA, VITROME, Marseille, France.
Hoang VT; IHU-Méditerranée Infection, Marseille, France; Aix Marseille Univ, IRD, AP-HM, SSA, VITROME, Marseille, France; Thai Binh University of Medicine and Pharmacy, Thai Binh, Vietnam.
Lagier JC; IHU-Méditerranée Infection, Marseille, France; Aix Marseille Univ, IRD, APHM, MEPHI, Marseille, France.
Raoult D; IHU-Méditerranée Infection, Marseille, France; Aix Marseille Univ, IRD, APHM, MEPHI, Marseille, France. Electronic address: .
Pokaż więcej
Źródło :
International journal of antimicrobial agents [Int J Antimicrob Agents] 2021 Jan; Vol. 57 (1), pp. 106239.
Typ publikacji :
Clinical Trial; Letter
MeSH Terms :
Antiviral Agents/*therapeutic use
Azithromycin/*therapeutic use
COVID-19/*drug therapy
COVID-19 Testing/*methods
Hydroxychloroquine/*therapeutic use
SARS-CoV-2/*drug effects
Aged ; Aged, 80 and over ; Anti-Bacterial Agents/therapeutic use ; Antimalarials/therapeutic use ; COVID-19/mortality ; COVID-19/virology ; Drug Combinations ; Drug Repositioning ; Drug Synergism ; Female ; Hospitalization/statistics & numerical data ; Humans ; Male ; Middle Aged ; Nasopharynx/virology ; RNA, Viral/genetics ; Reverse Transcriptase Polymerase Chain Reaction ; SARS-CoV-2/genetics ; SARS-CoV-2/pathogenicity ; Survival Analysis ; Treatment Outcome ; Viral Load/drug effects
Raport
Tytuł :
Potent inhibitory activity of taniborbactam towards NDM-1 and NDM-1 mutants, and in vitro activity of cefepime/taniborbactam against MBLs producing Enterobacterales.
Autorzy :
Piccirilli A; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
Segatore B; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
Brisdelli F; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
Amicosante G; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
Perilli M; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy. Electronic address: .
Pokaż więcej
Źródło :
International journal of antimicrobial agents [Int J Antimicrob Agents] 2021 Jan; Vol. 57 (1), pp. 106228. Date of Electronic Publication: 2020 Nov 24.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial revisited.
Autorzy :
Gautret P; IHU-Méditerranée Infection, Marseille, France; Aix Marseille Univ, IRD, AP-HM, SSA, VITROME, Marseille, France.
Lagier JC; IHU-Méditerranée Infection, Marseille, France; Aix Marseille Univ, IRD, APHM, MEPHI, Marseille, France.
Honoré S; Service Pharmacie, Hôpital Timone, AP-HM, Marseille, France; Laboratoire de Pharmacie Clinique, Aix Marseille Université, Marseille, France.
Hoang VT; IHU-Méditerranée Infection, Marseille, France; Aix Marseille Univ, IRD, AP-HM, SSA, VITROME, Marseille, France; Thai Binh University of Medicine and Pharmacy, Thai Binh, Vietnam.
Colson P; IHU-Méditerranée Infection, Marseille, France; Aix Marseille Univ, IRD, APHM, MEPHI, Marseille, France.
Raoult D; IHU-Méditerranée Infection, Marseille, France; Aix Marseille Univ, IRD, APHM, MEPHI, Marseille, France. Electronic address: .
Pokaż więcej
Źródło :
International journal of antimicrobial agents [Int J Antimicrob Agents] 2021 Jan; Vol. 57 (1), pp. 106243.
Typ publikacji :
Letter
MeSH Terms :
Antiviral Agents/*therapeutic use
Azithromycin/*therapeutic use
COVID-19/*drug therapy
Hydroxychloroquine/*therapeutic use
SARS-CoV-2/*drug effects
Anti-Bacterial Agents/therapeutic use ; Antimalarials/therapeutic use ; COVID-19/virology ; Clinical Trials as Topic ; Drug Combinations ; Drug Interactions ; Drug Repositioning ; Drug Synergism ; Electrocardiography ; Humans ; Long QT Syndrome/prevention & control ; Monitoring, Physiologic ; Patient Safety ; RNA, Viral/antagonists & inhibitors ; RNA, Viral/genetics ; SARS-CoV-2/genetics ; SARS-CoV-2/pathogenicity ; Treatment Outcome
Opinia redakcyjna
Tytuł :
Whole Genome Sequencing of Staphylococcus aureus SA-1199B Reveals Previously Unreported Mutations.
Autorzy :
Laws M; Institute of Pharmaceutical Sciences, School of Cancer and Pharmaceutical Sciences, King's College London, Franklin-Wilkins Building, 150 Stamford Street, London, SE1 9NH, UK.
Hind C; Public Health England, National Infection Service, Research and Development Institute, Porton Down, Salisbury, Wiltshire, SP4 0JG, UK.
Rahman KM; Institute of Pharmaceutical Sciences, School of Cancer and Pharmaceutical Sciences, King's College London, Franklin-Wilkins Building, 150 Stamford Street, London, SE1 9NH, UK.
Sutton JM; Public Health England, National Infection Service, Research and Development Institute, Porton Down, Salisbury, Wiltshire, SP4 0JG, UK.
Wand ME; Public Health England, National Infection Service, Research and Development Institute, Porton Down, Salisbury, Wiltshire, SP4 0JG, UK. Electronic address: .
Pokaż więcej
Źródło :
International journal of antimicrobial agents [Int J Antimicrob Agents] 2021 Jan; Vol. 57 (1), pp. 106225. Date of Electronic Publication: 2020 Nov 12.
Typ publikacji :
Letter
Opinia redakcyjna

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies